TNFRSF17 and plasma cell myeloma: BCMA is a marker for the identification of hematologic malignancies, including multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, chronic lymphocytic leukemia, and acute B-lymphoblastic leukemia [14].